Mein Warenkorb

Carbonic Anhydrase IX

Carbonic Anhydrase IX Molekülinformation

Englischer NameCarbonic anhydrase IXAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel16Target-AliasEC:4.2.1.1,Renal cell carcinoma-associated antigen G250,P54/58N,CA9,Carbonic Anhydrase 9,RCC-Associated Protein G250,Carbonate Dehydratase IX,Carbonic Dehydratase,CA-IX,CAIX,PMW1,MN,EC 4.2.1.1,G250,Carbonic anhydrase IX,Membrane antigen MN,RCC-associated antigen G250
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameCarbonic anhydrase IX
Target-AliasEC:4.2.1.1,Renal cell carcinoma-associated antigen G250,P54/58N,CA9,Carbonic Anhydrase 9,RCC-Associated Protein G250,Carbonate Dehydratase IX,Carbonic Dehydratase,CA-IX,CAIX,PMW1,MN,EC 4.2.1.1,G250,Carbonic anhydrase IX,Membrane antigen MN,RCC-associated antigen G250
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel16
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

Carbonic Anhydrase IX Produktliste

  • Attribut

    Protein (11)

  • Produktbibliothek

    Online (11)

  • Spezies

    Human (8)Mouse (1)Cynomolgus (2)

  • Etikett

    His Tag (7)His Tag & Avi Tag (2)Fc Tag (1)Fc Tag & Avi Tag (1)

  • Marker

    Unconjugated (5)Biotin-labeled (3)PE Labeled (1)FITC Labeled (1)APC Labeled (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
HOT
CA9-H5220
Human
HEK293
Human Carbonic Anhydrase IX / CA9 (138-414) Protein, His Tag (MALS verified)
In den Warenkorb legen
HOT
CA9-H5226
Human
HEK293
Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His Tag, low endotoxin (active enzyme, MALS verified)
In den Warenkorb legen
HOT
CA9-H5253
Human
HEK293
Human Carbonic Anhydrase IX / CA9 (38-414) Protein, Fc Tag (active enzyme, MALS verified)
In den Warenkorb legen
HOT
CA9-H82E3
Human
HEK293
Biotinylated Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His,Avitag™ (active enzyme, MALS verified)
In den Warenkorb legen
HOT
CA9-HP2H6
Human
HEK293
PE-Labeled Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His Tag (Site-specific conjugation)
In den Warenkorb legen
CA9-H82F5
Human
HEK293
Biotinylated Human Carbonic Anhydrase IX / CA9 (38-414) Protein, Fc,Avitag™ (MALS verified)
In den Warenkorb legen
CA9-HA2H7
Human
HEK293
APC-Labeled Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His Tag (Site-specific conjugation)
In den Warenkorb legen
CA9-HF228
Human
HEK293
FITC-Labeled Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His Tag (MALS verified)
In den Warenkorb legen
CA9-M52H3
Mouse
HEK293
Mouse Carbonic Anhydrase IX / CA9 (32-390) Protein, His Tag (active enzyme, MALS verified)
In den Warenkorb legen
CA9-C52H3
Cynomolgus
HEK293
Cynomolgus Carbonic Anhydrase IX Protein, His Tag (active enzyme, MALS verified) In den Warenkorb legen
Gesamtmenge11
  • 1
  • 2

Carbonic Anhydrase IX Molekülhintergrund

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. There are at least five distinct CA families (α, β, γ, δ and ε). Carbonic anhydrase 9 (CA9 / CAIX) is also known as Membrane antigen MN (MN), Renal cell carcinoma-associated antigen G250, which belongs to the alpha-carbonic anhydrase family. CA9 / CAIX with an optimal activity at pH 6.49. Reversible hydration of carbon dioxide. CA IX participates in pH regulation. CA9 may be involved in the control of cell proliferation and transformation. CA-IX appears to be a novel specific biomarker for a cervical neoplasia.

Carbonic Anhydrase IX Molekülalias

CAIX,CA9,CA-IX,G250,MN,P54,58N,pMW1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Girentuximab MAb-G250; cG250; WX-G250Phase 3 ClinicalWilex AGCarcinoma, Renal Cell; Kidney Neoplasms
Details
Girentuximab-Zr-8989Zr-TX250; TLX-250-CDx; 89Zr-TX-250; TLX250-CDx; 89Zr-TLX250Phase 3 ClinicalWilex AGCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Contrast agents; Esophageal Neoplasms; Glioblastoma; Nasopharyngeal Carcinoma; Sarcoma; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; von Hippel-Lindau Disease
Details
Lutetium-177 DOTA girentuximabTLX-250Phase 2 ClinicalHeidelberg Pharma AG, Telix Pharmaceuticals Ltd, Wilex AGCarcinoma, Renal Cell; Neoplasms
Details
[177Lu]Lu-DPI-4452[177Lu]Lu-DPI-4452; Debio 0228; ITM-91; 3BP-4452; 177Lu-DPI-4452Phase 2 Clinical3B Pharmaceuticals GmbHCarcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
Details
Debio-0328[68Ga]Ga-DPI-4452; Gallium-68-DPI-4452; ITM-94D; 68Ga-DPI-4452Phase 2 Clinical3B Pharmaceuticals GmbHCarcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
Details
68Ga-NY10468Ga-NYM005; 68Ga-NY-104Phase 2 ClinicalWuxi Nuoyu Pharmaceutical Technology Co LtdCarcinoma, Renal Cell
Details
PMI-05PMI-05Phase 1 ClinicalPrecision Molecular IncNeoplasms
Details
PHC-10299mTc-CAIX; PHC102; 99mTc-PHC-102Phase 1 ClinicalPhilochemCarcinoma, Renal Cell
Details
Indium-111-DOTA-girentuximab-IRDye800CW111In-girentuximab-F2Phase 1 ClinicalRadboud University NijmegenCarcinoma, Renal Cell; Diagnostic agents
Details
[211At]At-girentuximabPhase 1 ClinicalATONCO, Institut de Cancérologie de l'OuestUrinary Bladder Neoplasms
Details
[68Ga]Ga-OncoCAIX68Ga-OncoCAIX; [68Ga]Ga-OncoCAIXPhase 1 ClinicalPhilogen SpaCarcinoma, Renal Cell
Details
18F-NY10418F-NY104; 18F-NYM005Phase 1 ClinicalWuxi Nuoyu Pharmaceutical Technology Co LtdCarcinoma, Renal Cell; Contrast agents
Details
CA9hu-1CA9hu-1Phase 1 ClinicalMabpro ASCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Head and Neck Neoplasms; Mesothelioma; Triple Negative Breast Neoplasms
Details
Sulfamide-nitroimidazoleClinicalDualtpharmaNeoplasms
Details
68Ga-C1ClinicalThe First Affiliated Hospital Of Beijing UniversityCarcinoma, Renal Cell
Details
64Cu-PD-3276664Cu-PD-32766ClinicalPeptiDream IncCarcinoma, Renal Cell; Colorectal Neoplasms; Glioblastoma; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns